• Big Pharma in metro

    Mi segnalano che Roma è tappezzata di pubblicità per i vaccini HPV.

    Non ho tempo e voglia di dirvi quanto male penso di questo vaccino alluminioso e quali imbrogli hanno fatto per nascondere i pesanti effetti avversi sui nostri ragazzi, che invece vengono illusi di poter fare sesso senza rischi.

    Dico solo che è indecente e illegale che si faccia pubblicità ai farmaci senza scrivere le precauzioni e le controindicazioni. È indecente che le autorità sanitarie lascino fare questa propaganda della MSD (Merck) che è PAGATA dallo STATO (cioè da noi) comprando tali intrugli dalla casa farmaceutica. Quella stessa casa farmaceutica che poi usa i soldi (nostri) per pagare anche la OMS la quale poi promulga le raccomandazioni di usare gli stessi vaccini. Raccomandazioni che sono pedissequamente seguite dai funzionari del nostro Ministero della cosiddetta Salute.

    Possibile che nessuno intervenga?

    Fonte: https://t.me/libertasenzagreenpass/326344?single
    Big Pharma in metro Mi segnalano che Roma è tappezzata di pubblicità per i vaccini HPV. Non ho tempo e voglia di dirvi quanto male penso di questo vaccino alluminioso e quali imbrogli hanno fatto per nascondere i pesanti effetti avversi sui nostri ragazzi, che invece vengono illusi di poter fare sesso senza rischi. Dico solo che è indecente e illegale che si faccia pubblicità ai farmaci senza scrivere le precauzioni e le controindicazioni. È indecente che le autorità sanitarie lascino fare questa propaganda della MSD (Merck) che è PAGATA dallo STATO (cioè da noi) comprando tali intrugli dalla casa farmaceutica. Quella stessa casa farmaceutica che poi usa i soldi (nostri) per pagare anche la OMS la quale poi promulga le raccomandazioni di usare gli stessi vaccini. Raccomandazioni che sono pedissequamente seguite dai funzionari del nostro Ministero della cosiddetta Salute. Possibile che nessuno intervenga? Fonte: https://t.me/libertasenzagreenpass/326344?single
    Angry
    1
    0 Commenti 0 Condivisioni 2K Visualizzazioni
  • Oncology Market Rising Trends, Demand and Future Scope 2024 to 2031

    Leading market research firm SkyQuest Technology Group recently released a study titled 'Oncology Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Oncology report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Oncology Market extensively demonstrates existing and upcoming opportunities, profitability, revenue growth rates, pricing, and scenarios for recent industry analysis.

    The research analysis on the global Oncology Market report 2024 offers a close watch on top industry rivals along with briefings on their company profiles, strategical surveys, micro as well as macro industry trends, futuristic scenarios, analysis of pricing structure, and an all-encompassing overview of the Oncology Market circumstances in the forecast period between 2024 and 2031. The global Oncology Market is a dynamic and rapidly evolving sector, encompassing the development, production, and distribution. This market is essential for improving global market and driving economic growth through innovation and industry advancements.

    Market Growth

    The Oncology Market has experienced robust growth over the past decade and is projected to continue expanding. Oncology Market size was valued at USD 286.04 billion in 2022 and is poised to grow from USD 309.3 billion in 2023 to USD 581.25 billion by 2031, growing at a CAGR of 8.2% in the forecast period (2024-2031). This growth is driven by several factors, including an aging global population, increasing prevalence of advancements in technology, and rising global expenditure.

    Chance to get a free sample @ https://www.skyquestt.com/sample-request/oncology-market

    Detailed Segmentation and Classification of the report (Market Size and Forecast - 2031, Y-o-Y growth rate, and CAGR):

    The Oncology Market can be segmented based on several factors, including product type, application, end-user, and distribution channel. Understanding these segments is crucial for companies looking to target specific markets and tailor their offerings to meet consumer needs.

    Cancer Diagnostics & Treatment
    Cancer Diagnostics {Tumor Biomarker Test, Imaging, Biopsy, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization}, Cancer Treatment {Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy}
    Cancer Type
    Lung Cancer, Prostate Cancer, Colon & Rectal Cancer, Gastric Cancer, Esophageal Cancer, Liver Cancer, Breast Cancer
    End-Use
    Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Academia, Specialty Clinics
    Get your customized report @ https://www.skyquestt.com/speak-with-analyst/oncology-market

    Following are the players analyzed in the report:

    Roche Holding AG
    Novartis International AG
    Bristol-Myers Squibb Company
    Pfizer Inc.
    Merck & Co., Inc.
    AstraZeneca PLC
    Johnson & Johnson
    Sanofi S.A.
    Takeda Pharmaceutical Company Limited
    Amgen Inc.
    AbbVie Inc.
    Eli Lilly and Company
    Gilead Sciences, Inc.
    Celgene Corporation (a subsidiary of Bristol-Myers Squibb Company)
    Bayer AG
    Biogen Inc.
    Daiichi Sankyo Company, Limited
    Astellas Pharma Inc.
    Eisai Co., Ltd.
    Teva Pharmaceutical Industries Ltd.
    Regional Analysis

    1. North America:
    - The United States and Canada dominate the North American Oncology Market. The U.S. is the largest market globally, driven by advanced global infrastructure, high R&D investments, and significant Oncology consumption.

    2. Europe:
    - Europe is a significant player, with major Oncology Markets in Germany, France, and the United Kingdom. The region benefits from strong regulatory frameworks, high industry standards, and a robust R&D sector.

    3. Asia-Pacific:
    - This region is experiencing rapid growth, with countries like China and India leading the charge. Factors such as increasing industry access, growing middle-class populations, and expanding Oncology manufacturing capabilities contribute to this growth.

    4. Latin America:
    - Brazil and Mexico are key markets in Latin America. Growth in this region is driven by rising industry needs, increasing investments in industry infrastructure, and a growing demand for affordable medications.

    5. Middle East and Africa:
    - The Oncology Market in this region is expanding due to rising market spending, increased prevalence of diseases, and improvements in Market infrastructure, although the market is relatively smaller compared to other regions.

    Future Outlook

    The Oncology Market is poised for continued growth driven by technological advancements, expanding global market access, and increasing global industry needs. As the industry adapts to evolving challenges and seizes emerging opportunities, it is likely to see ongoing innovation and expansion, contributing significantly to global health and economic development.

    Buy your full report: https://www.skyquestt.com/buy-now/oncology-market
    Oncology Market Rising Trends, Demand and Future Scope 2024 to 2031 Leading market research firm SkyQuest Technology Group recently released a study titled 'Oncology Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Oncology report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Oncology Market extensively demonstrates existing and upcoming opportunities, profitability, revenue growth rates, pricing, and scenarios for recent industry analysis. The research analysis on the global Oncology Market report 2024 offers a close watch on top industry rivals along with briefings on their company profiles, strategical surveys, micro as well as macro industry trends, futuristic scenarios, analysis of pricing structure, and an all-encompassing overview of the Oncology Market circumstances in the forecast period between 2024 and 2031. The global Oncology Market is a dynamic and rapidly evolving sector, encompassing the development, production, and distribution. This market is essential for improving global market and driving economic growth through innovation and industry advancements. Market Growth The Oncology Market has experienced robust growth over the past decade and is projected to continue expanding. Oncology Market size was valued at USD 286.04 billion in 2022 and is poised to grow from USD 309.3 billion in 2023 to USD 581.25 billion by 2031, growing at a CAGR of 8.2% in the forecast period (2024-2031). This growth is driven by several factors, including an aging global population, increasing prevalence of advancements in technology, and rising global expenditure. Chance to get a free sample @ https://www.skyquestt.com/sample-request/oncology-market Detailed Segmentation and Classification of the report (Market Size and Forecast - 2031, Y-o-Y growth rate, and CAGR): The Oncology Market can be segmented based on several factors, including product type, application, end-user, and distribution channel. Understanding these segments is crucial for companies looking to target specific markets and tailor their offerings to meet consumer needs. Cancer Diagnostics & Treatment Cancer Diagnostics {Tumor Biomarker Test, Imaging, Biopsy, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization}, Cancer Treatment {Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy} Cancer Type Lung Cancer, Prostate Cancer, Colon & Rectal Cancer, Gastric Cancer, Esophageal Cancer, Liver Cancer, Breast Cancer End-Use Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Academia, Specialty Clinics Get your customized report @ https://www.skyquestt.com/speak-with-analyst/oncology-market Following are the players analyzed in the report: Roche Holding AG Novartis International AG Bristol-Myers Squibb Company Pfizer Inc. Merck & Co., Inc. AstraZeneca PLC Johnson & Johnson Sanofi S.A. Takeda Pharmaceutical Company Limited Amgen Inc. AbbVie Inc. Eli Lilly and Company Gilead Sciences, Inc. Celgene Corporation (a subsidiary of Bristol-Myers Squibb Company) Bayer AG Biogen Inc. Daiichi Sankyo Company, Limited Astellas Pharma Inc. Eisai Co., Ltd. Teva Pharmaceutical Industries Ltd. Regional Analysis 1. North America: - The United States and Canada dominate the North American Oncology Market. The U.S. is the largest market globally, driven by advanced global infrastructure, high R&D investments, and significant Oncology consumption. 2. Europe: - Europe is a significant player, with major Oncology Markets in Germany, France, and the United Kingdom. The region benefits from strong regulatory frameworks, high industry standards, and a robust R&D sector. 3. Asia-Pacific: - This region is experiencing rapid growth, with countries like China and India leading the charge. Factors such as increasing industry access, growing middle-class populations, and expanding Oncology manufacturing capabilities contribute to this growth. 4. Latin America: - Brazil and Mexico are key markets in Latin America. Growth in this region is driven by rising industry needs, increasing investments in industry infrastructure, and a growing demand for affordable medications. 5. Middle East and Africa: - The Oncology Market in this region is expanding due to rising market spending, increased prevalence of diseases, and improvements in Market infrastructure, although the market is relatively smaller compared to other regions. Future Outlook The Oncology Market is poised for continued growth driven by technological advancements, expanding global market access, and increasing global industry needs. As the industry adapts to evolving challenges and seizes emerging opportunities, it is likely to see ongoing innovation and expansion, contributing significantly to global health and economic development. Buy your full report: https://www.skyquestt.com/buy-now/oncology-market
    WWW.SKYQUESTT.COM
    Oncology Market Size, Growth & Trends Report | 2031
    Oncology Market By Cancer Diagnostics & Treatment(Cancer Diagnostics {Tumor Biomarker Test, Imaging), By Cancer Type(Lung Cancer, Prostate Cancer), By End-Use(Hospitals, Diagnostic Laboratories) and By Region.
    0 Commenti 0 Condivisioni 8K Visualizzazioni
  • Brad Setser, economista bravo, che spiega
    che le big Pharma USA, Merck, Pfizer, Glaxo, ecc.. eludono almeno 10 miliardi di tasse l'anno
    mentre ad es in Danimarca Novo non elude...
    https://twitter.com/Brad_Setser/status/1768035996484997127?t=_fVBslgs1lvbldrO1GInXw&s=19
    Brad Setser, economista bravo, che spiega che le big Pharma USA, Merck, Pfizer, Glaxo, ecc.. eludono almeno 10 miliardi di tasse l'anno mentre ad es in Danimarca Novo non elude... https://twitter.com/Brad_Setser/status/1768035996484997127?t=_fVBslgs1lvbldrO1GInXw&s=19
    0 Commenti 0 Condivisioni 1K Visualizzazioni
  • Video censurato da Facebook e pubblicato su Napebook.com - il Social contro la censura.

    I soldi delle case farmaceutiche a chi decide sui vaccini: SItI (società italiana di igiene) FIMMG (Federazione italiana dei medici di famiglia) fimp (federazione italiana medici pediatri) e SIP (Società italiana di Pediatria).

    MASSIMA CONDIVISIONE!!!

    #collusioneordinipediatrici
    #societaitalianpediatria
    #confliettodiinteressi
    #merck
    #gsk
    #sanofi
    #pfizer
    Video censurato da Facebook e pubblicato su Napebook.com - il Social contro la censura. I soldi delle case farmaceutiche a chi decide sui vaccini: SItI (società italiana di igiene) FIMMG (Federazione italiana dei medici di famiglia) fimp (federazione italiana medici pediatri) e SIP (Società italiana di Pediatria). MASSIMA CONDIVISIONE!!! #collusioneordinipediatrici #societaitalianpediatria #confliettodiinteressi #merck #gsk #sanofi #pfizer
    Angry
    2
    1 Commenti 0 Condivisioni 9K Visualizzazioni 42